pathology microbiology and immunology Archives
Medical societies honor VUMC’s Cover, Williams
Jun. 11, 2015—Two physicians from Vanderbilt University have been elected to membership in two of the nation’s oldest and most respected medical honor societies — the Association of American Physicians (AAP) and the American Society for Clinical Investigation (ASCI).
Study identifies C. diff toxin receptor, suggests new treatment approaches
Jun. 4, 2015—Vanderbilt University investigators have identified a cellular receptor for a toxin from Clostridium difficile (“C. diff”) — the leading cause of hospital-acquired diarrhea in the United States.
Vanderbilt University honors 28 as emeriti faculty
May. 8, 2015—Twenty-eight retiring faculty members were recognized during Vanderbilt’s Commencement ceremony May 8, when the university honored their years of service and bestowed on them the title of emeritus or emerita faculty.
Kids more likely to react to blood transfusions
May. 4, 2015—Pediatric patients have a significantly higher incidence of transfusion reactions compared to adults, according to a study by Vanderbilt University researchers.
RNA defects in multiple sclerosis
Apr. 30, 2015—Vanderbilt researchers have discovered that profound defects exist in the integrity of structural RNA molecules in patients with relapsing remitting multiple sclerosis.
Cates lands grant to study desmoid tumor genetic factors
Apr. 16, 2015—The Desmoid Tumor Research Foundation (DTRF) has awarded Justin Cates, M.D., Ph.D., associate professor of Pathology, Microbiology and Immunology, with one of its five research grants for his work studying growth/recurrence determinants related to genetic factors in desmoid-type fibromatosis (DTF) patients.
Contributors to coronavirus ‘fitness’
Feb. 24, 2015—Understanding the role that host membrane modification plays in coronavirus replication is essential for developing novel approaches to block the viruses that cause SARS and MERS.
Targeting HIV’s “cap”
Feb. 10, 2015—New findings underscore the attractiveness of the HIV capsid – the structure that encloses the viral genome – as a therapeutic target.
Vanderbilt-led team studies blood test for prostate cancer
Jan. 5, 2015—Vanderbilt University researcher William Mitchell, M.D., Ph.D., and colleagues in Germany and Canada have demonstrated a method for detecting “cell-free” tumor DNA in the bloodstream.
Target for atherosclerosis therapies
Dec. 17, 2014—A newly identified “atheroprotective” gene is a tool for exploring plaque pathophysiology and may be a good target for therapies to slow atherosclerosis progression.
Bacterial secretion machinery: 3-D view
Dec. 11, 2014—New structural findings reveal how "gatekeeper" proteins participate in the secretion systems bacteria use to infect host cells.
Physician-scientist is dream job for Vanderbilt’s Cassat
Dec. 4, 2014—Jim Cassat, M.D., Ph.D., a pediatric infectious disease specialist who joined the Vanderbilt faculty this summer, loves taking care of children with bone infections and doing research to understand the host-pathogen interactions during these invasive infections.
